Alken Asset Management »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Alken Asset Management

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Alken Asset Management from 13F filings

Historical chart of Alken Asset Management investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Alken Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Alken Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.5M 1.3k 1189.23
2024-06-30 $1.4M 1.3k 1107.69